MONTREAL, CANADA--(Marketwire - April 10, 2008) - ART Advanced Research Technologies Inc. (“ART”)(TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, will be exhibiting at the Annual Meeting of the American Association for Cancer Research (AACR), April 13-16, in San Diego, CA. ART will showcase its preclinical product offering, including current research in the oncological and pharmacokinetics fields using the Optix® MX2 optical imaging device, as well as the Fenestra® line of contrast agents for microCT imaging, at its booth (#1007) located in the San Diego Convention Center.
